{"nctId":"NCT00131573","briefTitle":"An Implantable Microstimulator for the Chronic Treatment of Urinary Urgency-Frequency Syndrome","startDateStruct":{"date":"2004-05"},"conditions":["Overactive Bladder"],"count":118,"armGroups":[{"label":"1","type":"EXPERIMENTAL","interventionNames":["Device: bion"]},{"label":"2","type":"SHAM_COMPARATOR","interventionNames":["Device: bion"]}],"interventions":[{"name":"bion","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Key Inclusion criteria:\n\n* Age 18 years and above.\n* Diagnosed with urinary urgency-frequency syndrome.\n* Have no reported history of urethral obstruction/stricture, bladder calculi or bladder tumor.\n* Have normal upper urinary tract function.\n* Be capable of giving informed consent.\n* Be capable and willing to follow all study related procedures.\n\nKey Exclusion Criteria:\n\n* Have any active implantable device regardless of whether stimulation status is ON or OFF.\n* Are pregnant as confirmed by a urine pregnancy test or plan to become pregnant during the following 12 month period.\n* Less than one year post partum and/or are breast-feeding.\n* Have any large passive implant that contains metal located within 30 cm of the chair pad while seated (e.g., hip replacement).\n* Have conditions requiring magnetic resonance imaging (MRI) evaluation.\n* Have conditions requiring diathermy procedures.\n* Have an inability to operate the bion Remote Control and bion Recharging System either by self or caregiver.\n* Have diabetes with peripheral nerve involvement or have severe uncontrolled diabetes.\n* Have history of coagulopathy or bleeding disorder.\n* Have pelvic pain in the absence of voiding dysfunction.\n* Have anatomical restrictions such that the study device placement is not possible.\n* Are currently participating or have participated within the past 30 days in any clinical investigation involving or impacting urinary or renal function.\n* Cannot independently comprehend and complete the questionnaires.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Average Number of Voids Per Day","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":"NA"},{"groupId":"OG001","value":"NA","spread":"NA"}]}]}]},{"type":"PRIMARY","title":"Freedom From Major Complications","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":46},"commonTop":["Therapeutic Product Ineffective","Therapeutic Response Decreased","Pelvic Pain","Implant site Pain","Device Migration"]}}}